COGT
COGT
NASDAQ · Biotechnology

Cogent Biosciences Inc

$34.96
-0.45 (-1.27%)
As of Mar 24, 9:52 PM ET ·
Financial Highlights (FY 2025)
Revenue
1.66B
Net Income
-282,006,496
Gross Margin
66.0%
Profit Margin
-17.0%
Rev Growth
-0.8%
D/E Ratio
0.59
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 66.0% 66.0% 66.0%
Operating Margin -16.1% -17.1% -17.7%
Profit Margin -17.0% -20.2% -17.2%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.66B 1.76B 1.56B
Gross Profit 1.10B 1.16B 1.03B
Operating Income -268,135,908 -301,295,159 -275,398,636
Net Income -282,006,496 -354,880,166 -268,142,716
Gross Margin 66.0% 66.0% 66.0%
Operating Margin -16.1% -17.1% -17.7%
Profit Margin -17.0% -20.2% -17.2%
Rev Growth -0.8% +1.9% -1.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.15B 1.84B 2.13B
Total Equity 3.66B 3.39B 3.86B
D/E Ratio 0.59 0.54 0.55
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -474,772,680 -496,954,417 -453,512,070
Free Cash Flow -249,995,996 -301,722,393 -268,935,506